J Korean Assoc Oral Maxillofac Surg.  2008 Dec;34(6):649-652.

Osteoblastoma of the mandible: A case report

Affiliations
  • 1Department of Oral & Maxillofacial Surgery, St. Mary's Hospital, The Catholic University of Korea, Korea. justina@catholic

Abstract

Osteoblastoma is a relatively rare benign bone tumor representing less than 1% of all bone tumors. The tumor usually involves the spine and sacrum of young individuals, less than 10% being localized to the skull, and nearly half of these affect the mandible, especially the posterior segments. In clinical finding, osteoblastoma present mainly with pain, swelling, and expansion of bone cortex. Radiographic appearances are variable, but frequently a well-delineated radiolucent lesion containing varying amounts of mineral deposits is seen. Histologically, ostoeblastoma is consists of irregular trabeculeae of osteoid and immature bone present within highly vascular connective tissue matrix. Osteoblastoma must be differentiated from a number of bone-producing lesions, including osteoid osteoma, fibrous dysplasia, ossifying fibroma, fibrous dysplasia, and osteosarcoma. If diagnosis may be mistaken for osteosarcoma, there are risks of more aggressive and irreversible treatment. Differential diagnosis of osteoblastoma is important. The preferred treatment of osteoblastoma is conservative approach and surgical excision. Recurrence following surgical intervention is rare. We treated osteoblastoma located in premolar area of mandible by excision with preservation of vital structure, such as nerves and teeth. So we report our clinical treatment with literature review

Keyword

Osteoblastoma; Mandible; Bone tumor

MeSH Terms

Bicuspid
Connective Tissue
Diagnosis, Differential
Fibroma, Ossifying
Mandible
Osteoblastoma
Osteoma, Osteoid
Osteosarcoma
Recurrence
Sacrum
Skull
Spine
Tooth
Full Text Links
  • JKAOMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr